Monday, September 26, 2016

Dual aspirin and anticoagulant therapy in patients with atrial fibrillation.

In patients with non-valvular atrial fibrillation, there appears to be
no or little benefit of aspirin therapy in addition to coumadin therapy.
Dual antiplatelet and anticoagulant therapy increases major bleeding
risk. J Thromb Thrombolysis. 2016 Sep 24;

Comment:
There may be a role for dual antiplatelet / anticoagulant therapy in
patients with non-valvular atrial fibrillation who are within 12 months
of acute coronary syndrome or revascularization. However, with these
exclusions in place, the researchers still found that 45% of the
patients in their retrospective review were receiving both an
anticoagulant and aspirin.